Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Positive pivotal trial results for enzyme replacement therapy to be submitted with BLA

Nov. 2, 1998

Inhibition of ceramide glucosyltransferase as a novel therapeutic target

Nov. 2, 1998

PIXY-321 performs favorably in children; compound unfortunately no longer in development

Nov. 2, 1998

Selective, nonpeptide Y1 receptor antagonist reduces NPY-mediated food intake in rats

Nov. 2, 1998

HMR presents new agents for lipid disorders

Nov. 2, 1998

Licensing opportunity from the NIH: technology for enhancing embryo implantation

Nov. 2, 1998

BioStratum's Pyridorin effective for diabetic nephropathy

Oct. 30, 1998

Oral insulin formulation developed at Generex headed for U.S. clinical trials

Oct. 30, 1998

Novel vitamin D compounds claimed for use in bone disorders and psoriasis

Oct. 30, 1998

Thiocarbamic acid derivatives as inhibitors of squalene epoxidase

Oct. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...